Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 1
1978 1
1979 1
1981 1
1982 2
1983 3
1984 4
1985 3
1986 4
1987 5
1988 7
1989 7
1990 5
1991 5
1992 10
1993 2
1994 4
1995 9
1996 13
1997 14
1998 5
1999 13
2000 15
2001 17
2002 13
2003 12
2004 13
2005 26
2006 32
2007 28
2008 23
2009 31
2010 29
2011 35
2012 46
2013 47
2014 54
2015 58
2016 73
2017 63
2018 65
2019 97
2020 88
2021 114
2022 123
2023 111
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

1,159 results

Results by year

Filters applied: . Clear all
Page 1
Restaging MRI of Rectal Adenocarcinoma after Neoadjuvant Chemoradiotherapy: Imaging Findings and Potential Pitfalls.
Awiwi MO, Kaur H, Ernst R, Rauch GM, Morani AC, Stanietzky N, Palmquist SM, Salem UI. Awiwi MO, et al. Radiographics. 2023 Apr;43(4):e220135. doi: 10.1148/rg.220135. Radiographics. 2023. PMID: 36927125
Rectal adenocarcinoma constitutes about one-third of all colorectal adenocarcinoma cases. ...In this article, the authors discuss the indications for neoadjuvant therapy in management of patients with rectal adenocarcinoma, describe expected imaging ap
Rectal adenocarcinoma constitutes about one-third of all colorectal adenocarcinoma cases. ...In this article, the authors disc
Current Surgical Strategies for the Treatment of Rectal Adenocarcinoma and the Risk of Local Recurrence.
Longchamp G, Meyer J, Abbassi Z, Sleiman M, Toso C, Ris F, Buchs NC. Longchamp G, et al. Dig Dis. 2021;39(4):325-333. doi: 10.1159/000511959. Epub 2020 Oct 2. Dig Dis. 2021. PMID: 33011726 Free article. Review.
BACKGROUND: Despite new medical and surgical strategies, 5-year local recurrence of rectal adenocarcinoma was reported in up to 25% of cases. Therefore, we aimed to review surgical strategies for the prevention of local recurrences in rectal cancer. SUMMARY: After i …
BACKGROUND: Despite new medical and surgical strategies, 5-year local recurrence of rectal adenocarcinoma was reported in up t …
Survival outcomes of anal adenocarcinoma versus rectal adenocarcinoma: A retrospective cohort study.
Mankarious MM, Hughes AJ, Berg AS, Scow JS, Jeganathan AN, Kulaylat AS, Deutsch MJ. Mankarious MM, et al. Indian J Gastroenterol. 2023 Oct;42(5):694-700. doi: 10.1007/s12664-023-01394-0. Epub 2023 Aug 31. Indian J Gastroenterol. 2023. PMID: 37648878
BACKGROUND: Anal adenocarcinoma (AA) is a rare malignancy with decreased survival compared to rectal adenocarcinoma (RA). However, AA continues to be treated with similar algorithms compared to rectal cancer with minimal data regarding the efficacy of these treatmen …
BACKGROUND: Anal adenocarcinoma (AA) is a rare malignancy with decreased survival compared to rectal adenocarcinoma (RA). Howe …
Trends in the Characteristics, Treatment, and Outcomes of Rectal Adenocarcinoma in the US From 2004 to 2019: A National Cancer Database Analysis.
Emile SH, Horesh N, Freund MR, Garoufalia Z, Gefen R, Silva-Alvarenga E, Maron DJ, DaSilva G, Wexner SD. Emile SH, et al. JAMA Oncol. 2023 Mar 1;9(3):355-364. doi: 10.1001/jamaoncol.2022.6116. JAMA Oncol. 2023. PMID: 36580307 Free PMC article.
OBJECTIVE: This study aimed to evaluate trends in the characteristics, treatment, and outcomes of rectal adenocarcinoma across 16 years. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, observational case series study used data from the National Cancer Databas …
OBJECTIVE: This study aimed to evaluate trends in the characteristics, treatment, and outcomes of rectal adenocarcinoma across …
Benign and malignant tumors of the rectum and perirectal region.
Purysko AS, Coppa CP, Kalady MF, Pai RK, Leão Filho HM, Thupili CR, Remer EM. Purysko AS, et al. Abdom Imaging. 2014 Aug;39(4):824-52. doi: 10.1007/s00261-014-0119-8. Abdom Imaging. 2014. PMID: 24663381 Review.
Although most rectal masses are histologically characterized as adenocarcinomas, the rectum and perirectal region can be affected by a wide variety of tumors and tumor-like conditions that can mimic the symptoms caused by rectal adenocarcinoma, including mucosal or …
Although most rectal masses are histologically characterized as adenocarcinomas, the rectum and perirectal region can be affected by a wide …
Overall Survival After Treatment Failure Among Patients With Rectal Cancer.
Diefenhardt M, Martin D, Fleischmann M, Hofheinz RD, Ghadimi M, Rödel C, Fokas E. Diefenhardt M, et al. JAMA Netw Open. 2023 Oct 2;6(10):e2340256. doi: 10.1001/jamanetworkopen.2023.40256. JAMA Netw Open. 2023. PMID: 37902752 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study is a post hoc analysis of 3 randomized phase 2 or 3 trials (CAO/ARO/AIO-94, -04, and -12 trials, conducted in Germany) that included 1948 patients with locally advanced rectal adenocarcinoma. The CAO/ARO/AIO-94 tr …
DESIGN, SETTING, AND PARTICIPANTS: This cohort study is a post hoc analysis of 3 randomized phase 2 or 3 trials (CAO/ARO/AIO-94, -04, and -1 …
Prognosis of anal canal adenocarcinoma versus lower rectal adenocarcinoma in Japan: a propensity score matching study.
Saiki Y, Yamada K, Tanaka M, Fukunaga M, Irei Y, Suzuki T. Saiki Y, et al. Surg Today. 2022 Mar;52(3):420-430. doi: 10.1007/s00595-021-02350-1. Epub 2021 Aug 5. Surg Today. 2022. PMID: 34355283
The aim of this retrospective study was to identify the characteristics and PFs of AC, using population-based data in Japan. METHODS: Patients with AC (n = 390) or lower rectal adenocarcinoma (LR) (n = 12,477) diagnosed between1991 and 2006 were enrolled in this stu …
The aim of this retrospective study was to identify the characteristics and PFs of AC, using population-based data in Japan. METHODS: Patien …
Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma.
Hall WA, Li J, You YN, Gollub MJ, Grajo JR, Rosen M, dePrisco G, Yothers G, Dorth JA, Rahma OE, Russell MM, Gross HM, Jacobs SA, Faller BA, George S, Al Baghdadi T, Haddock MG, Valicenti R, Hong TS, George TJ. Hall WA, et al. J Clin Oncol. 2023 Oct 10;41(29):4643-4651. doi: 10.1200/JCO.22.02525. Epub 2023 Jul 21. J Clin Oncol. 2023. PMID: 37478389

PURPOSE: Total neoadjuvant therapy (TNT) is a newly established standard treatment for rectal adenocarcinoma. Current methods to communicate magnitudes of regression during TNT are subjective and imprecise. ...MR-TRG scores were associated with pCR (P < .01) and

PURPOSE: Total neoadjuvant therapy (TNT) is a newly established standard treatment for rectal adenocarcinoma. Current methods …
Local magnetic resonance imaging staging of rectal adenocarcinoma.
Sprouse T, Jensen CT, Vicens R, Ernst R, Bhosale P. Sprouse T, et al. J Comput Assist Tomogr. 2014 Nov-Dec;38(6):885-9. doi: 10.1097/RCT.0000000000000170. J Comput Assist Tomogr. 2014. PMID: 25333479 Review.
Successful multidisciplinary evaluation of potentially resectable rectal adenocarcinoma depends on high-resolution preoperative magnetic resonance imaging (MRI). ...Herein, we review MRI imaging and rectal anatomy related to the staging of rectal adenocarc
Successful multidisciplinary evaluation of potentially resectable rectal adenocarcinoma depends on high-resolution preoperativ …
Inguinal lymph node metastases from rectal adenocarcinoma: a systematic review.
Wyatt J, Powell SG, Ahmed S, Arthur J, Altaf K, Ahmed S, Javed MA. Wyatt J, et al. Tech Coloproctol. 2023 Nov;27(11):969-978. doi: 10.1007/s10151-023-02826-x. Epub 2023 May 26. Tech Coloproctol. 2023. PMID: 37233960 Free PMC article. Review.
PURPOSE: Inguinal lymph nodes are a rare but recognised site of metastasis in rectal adenocarcinoma. No guideline or consensus exists for the management of such cases. ...
PURPOSE: Inguinal lymph nodes are a rare but recognised site of metastasis in rectal adenocarcinoma. No guideline or consensus …
1,159 results